Articles about Product Safety

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Co-Dx (CODX) Q2 2026 Earnings Call Transcript ↗

August 20, 2026

Via The Motley Fool

Eton Pharmaceuticals (ETON) Q2 2026 Earnings Call Transcript ↗

August 20, 2026

Via The Motley Fool

Capricor (CAPR) Q2 2026 Earnings Call Transcript ↗

August 20, 2026

Via The Motley Fool

Considering Ketamine Therapy? What You Need to Know to Stay Safe

August 20, 2026

Via Brandpoint

Kaplan Fox Encourages Investors of Capricor Therapeutics, Inc. (NASDAQ: CAPR) to Contact the Firm to Learn About Their Legal Rights

August 20, 2026

Via NewMediaWire

There’s a Black Market for Eli Lilly’s Unapproved GLP-1 Drug. Here’s Why That’s Bullish ↗

August 20, 2026

Via The Motley Fool

Elutia (ELUT) Q2 2026 Earnings Call Transcript ↗

August 20, 2026

Via The Motley Fool

Daré Bioscience (DARE) Q2 2026 Earnings Call Transcript ↗

August 20, 2026

Via The Motley Fool

ADC Therapeutics (ADCT) Q2 2026 Earnings Call Transcript ↗

August 20, 2026

Via The Motley Fool

MDLN Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages Medline Inc. (MDLN) Investors to Contact the Firm

August 20, 2026

Via NewMediaWire

TechMediaBreaks – SS Innovations International Inc. (NASDAQ: SSII) Combines Medtech Leadership, Surgeon Training to Drive Robotic Surgery Expansion

August 20, 2026

Via Investor Brand Network

How to choose clinical trial solutions when study risk should drive the decision ↗

August 20, 2026

Via Talk Markets

Kaplan Fox Alerts Investors to an Upcoming Deadline of September 28, 2026 in the Capricor Therapeutics, Inc. (NASDAQ: CAPR) Securities Class Action

August 20, 2026

Via NewMediaWire

Kaplan Fox Announces an Investigation of Medline Inc. (NASDAQ: MDLN) on Behalf of Investors

August 20, 2026

Via NewMediaWire

NeuroOne (NMTC) Q3 2026 Earnings Call Transcript ↗

August 20, 2026

Via The Motley Fool

Johnson & Johnson Just Sent Shareholders an Important 11-Word Message About Its Future ↗

August 20, 2026

Via The Motley Fool

Cellectar Biosciences (CLRB) Q2 2026 Earnings Call Transcript ↗

August 20, 2026

Via The Motley Fool

Alvotech Q2 Earnings Call Highlights ↗

August 20, 2026

Via MarketBeat

Ascendis Pharma (ASND) Q2 2026 Earnings Call Transcript ↗

August 20, 2026

Via The Motley Fool

Regeneron Secures FDA Approval For Ultra-Rare Bone Disorder Drug ↗

August 20, 2026

Via Benzinga

Kaplan Fox is Investigating Potential Securities Law Violations Against Fulcrum Therapeutics, Inc. (NASDAQ: FULC)

August 20, 2026

Via NewMediaWire

Ultragenyx Nabs FDA Nod for First Gene Therapy ↗

August 20, 2026

Via Benzinga

Ultragenyx Wins FDA Approval for GENGLYCOS, Its First Gene Therapy ↗

August 20, 2026

Via MarketBeat

Biosimulation Market Analysis by Product and Application ↗

August 20, 2026

Via Talk Markets

FDA First Cycle Review of Preservative-Free Ketamine ANDA with No Drug Related Major Deficiencies Noted for Suicidal Bipolar Depression Treatment from NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)

August 20, 2026

Via Get News

Trump’s FDA Pick Heidi Overton Faces Republican Resistance as Bill Cassidy Calls Vaccine Order Role ‘Almost Disqualifying’ ↗

August 20, 2026

Via Benzinga

Kaplan Fox & Kilsheimer LLP Alerts Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to the Lead Plaintiff Deadline on September 28, 2026

August 19, 2026

Via NewMediaWire

Clene Eyes Q4 NDA for ALS Drug After FDA-Requested Biomarker Analyses ↗

August 19, 2026

Via MarketBeat

Longeveron (LGVN) Q2 2026 Earnings Call Transcript ↗

August 19, 2026

Via The Motley Fool

Stock Market Today, Aug. 19: Moderna Skyrockets 177% on Positive Phase 3 Melanoma Data ↗

August 19, 2026

Via The Motley Fool

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.